Literature DB >> 11793639

Managing the pharmaceutical industry-health system interface.

B J Zarowitz, B Muma, P Coggan, G Davis, G L Barkley.   

Abstract

BACKGROUND: Direct-to-consumer advertising, media, and Internet marketing to physicians and patients, as well as enticing marketing strategies, are used by the pharmaceutical industry to ensure market share growth of new drugs. Our health system adopted a strict vendor policy governing detailing and sampling activities of pharmaceutical representatives, but realized that further analysis of vendor influence in our system was needed.
OBJECTIVE: An assessment of tangible benefits, ethical concerns, and financial liabilities and gains was conducted to reassess the need for further vendor restriction.
CONCLUSIONS: Based on our findings, several recommendations have been made. Medical practices and health systems are encouraged to establish and enforce explicit vendor policies, measure their effectiveness, partner proactively with representatives to deliver a drug-detailing message consistent with system initiatives, monitor and regulate continuing medical education funding, and implement strategies to ensure appropriate drug use.

Entities:  

Mesh:

Year:  2001        PMID: 11793639     DOI: 10.1345/aph.10412

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  2 in total

1.  Resident and faculty perceptions of conflict of interest in medical education.

Authors:  Peter Y Watson; Akshay K Khandelwal; Joseph L Musial; John D Buckley
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

2.  Influences on prescribing.

Authors:  J W Foppe van Mil
Journal:  Pharm World Sci       Date:  2006-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.